Current Lab projects:
Identification of new proteins involved in the secretory pathway
Recently, a genome-wide RNAi screen
has been carried out in our lab in order to identify Drosophila proteins
involved in the secretory pathway (Bard et al. 2006).
In this screen, a fusion protein between the signal peptide of Drosophila's
BiP chaperone and horseradish peroxidase (SS-HRP) was used as a reporter
of constitutive protein secretion in fly cells. Out of the 22,000
analyzed double stranded RNAs (dsRNAs), 1,133 were found to block SS-HRP
secretion in a significant manner. However, most of these dsRNAs affected
SS-HRP secretion in an indirect way, for instance by targeting genes whose
products are involved in gene transcription, mRNA translation, cell survival or
basic cell metabolism. Thus, from the original 1,133 dsRNAs we ended up
selecting 130 whose targets are potential secretory genes. In fact, 26 of
these 130 genes encode proteins known to be necessary for protein transport,
thus validating our experimental approach.
With the remaining 104 fruit fly
genes, 77 of which have human orthologs, a secondary RNAi screen was
performed, this time in order to assess which of these genes are required for
the maintenance of Golgi morphology. To this end, a Drosophila cell line
stably expressing a fusion protein between the Golgi enzyme mannosidase II and
the green fluorescent protein (ManII-GFP) was transfected with each of these
104 dsRNAs and their effects on Golgi structure were monitored by fluorescence
microscopy. Of the 104 studied dsRNAs, 13 caused ManII-GFP to relocate to the
endoplasmic reticulum (ER) (class A genes), 19 induced the fragmentation of
Golgi membranes into smaller vesicles (class B genes) and 6 caused Golgi
membranes to swell and lose its usual cisternal appearance (class C genes). The
rest of dsRNAs did not affect Golgi morphology as compared to non-transfected
cells (class D genes).
Thus, our screen has identified about
a hundred new genes potentially involved in protein trafficking. Of these, about
40% also appear to regulate Golgi morphology, further indicating that they
probably are bona fide secretory pathway components. More than twenty of these
genes have already been cloned in our lab and their intracellular localization
been determined in fly cells. Many localize in the ER, Golgi or in vesicular
structures, consistent with their presumed role in protein secretion. Many of
the genes we have found had not previously been named, so we have
"christened" them as the TANGO genes (Transport ANd Golgi
Organization).
Future research in this area will
consist in a more detailed characterization of the individual TANGO genes and
their mammalian homologs. Some of the major questions we want to address are:
why does depletion of these proteins inhibit secretory traffic? (i.e. what is
the function of these proteins?), where are these proteins located in the
cell?, at what step in the secretory pathway is protein transport blocked when
these proteins are depleted?. Finding answers to these and other related
questions should shed much light to the still relatively obscure field of
secretory membrane traffic.
Mechanisms of Golgi-to-PM carrier formation at the TGN
The trans-Golgi network (TGN) is one
of the most important sorting stations in the secretory pathway. From the TGN,
transport carriers are formed that will eventually deliver their cargo to
either the apical or basolateral plasma membrane (PM), endosomes,
lysosomes, secretory granules, the endoplasmic reticulum or the Golgi cisternae
that precede the TGN. Given this large number of potential subcellular
destinations, it is no wonder that the detailed mechanisms
underlying sorting decisions at the TGN are still poorly understood. Our
lab is specifically focused on Golgi-to-PM transport carrier formation.
Previous research carried out in this
lab has already unveiled several important players in Golgi-to-PM traffic. In
this respect, a crucial finding was that of the role of protein kinase D (PKD)
in regulating the fission of PM-bound carriers at the TGN (Liljedahl et al. 2001). Part of the importance of this
discovery was that it shed light on the biological relevance of previous
data obtained from in vitro Golgi fragmentation assays. As a matter of
fact, PKD itself had been found to be required to fragment the Golgi in
these assays, which it did after being activated by the beta-gamma subunit of a
heterotrimeric G protein (Jamora et al. 1997 & 1999).
Therefore, it was now possible to devise a working model of Golgi-to-PM carrier
formation according to which the activation in the TGN of a heterotrimeric G
protein would lead to the dissociation of its alpha and beta-gamma subunits,
whereupon the latter would go on to activate PKD, which would in turn
induce the fission of the carrier from the TGN, thus allowing its transport to
the PM.
Needless to say, this is a very
simplified model and all our work since its formulation has gone in the
direction of closing some of its gaps. For instance, more recent research
has brought new players into the game, including the lipid diacylglycerol,
which binds PKD and recruits it to the TGN (Baron &
Malhotra 2002) and PKC-eta, which appears to be acting downstream of
beta-gamma but still upstream of PKD (Diaz-Añel
& Malhotra 2005). Our current research is aimed at characterizing
still other proteins or lipids that take part in this process, as well as the
interactions between all the components involved.
In any case, there are still many
important questions awaiting an answer. After all, before PKD can induce the fission
of carriers at the TGN (how it does so is not yet clear, though it appears to
involve synthesis of another phospholipid, PI4P (Hausser
et al. 2005)), these carriers must have budded from the TGN, which
presumably involves both lipids and proteins that can generate the needed
membrane curvature, and must also have been filled with the
appropriate cargo. Another unanswered question is what activates the
above-mentioned G protein: an appealing possibility is the existence of a
Golgi-localized, cargo-activated G protein-coupled receptor. However, this
receptor, if it indeed exists, has so far remained elusive.
In summary, understanding
the mechanisms whereby Golgi-to-PM carriers bud from the TGN, are filled
with cargo and are detached and how these different events are coordinated with
each other so that they occur at the right time and to the desired extent
represents a magnificent scientific challenge. It is our belief that a
reductionist approach based on the identification of all the major players
as well as their mutual interactions will eventually lead to the solution of
this problem.
Golgi inheritance during mitosis and the Golgi checkpoint.
The mechanisms of Golgi membrane
inheritance during mitosis are the subject of intensive research as well as of
ongoing controversy (Colanzi et al. 2003a; Shorter
& Warren 2002). Such mechanisms have been shown to vary considerably
in different eukaryotic organisms (Rossanese &
Glick 2001; Pelletier et al. 2002; He et al. 2004 & 2005), but here
we will focus on what happens in mammalian cells. The mammalian Golgi apparatus
is inherited in three consecutive steps, namely (1) Golgi fragmentation during
late prophase and metaphase, (2) partitioning of the resulting Golgi haze into
daughter cells during anaphase and (3) Golgi reassembly in telophase.
In our lab, we focus mainly in the
first of these steps, i.e. mitotic Golgi fragmentation. This is a complex
process involving two distinct phases. In the first one,
the lateral connections between Golgi stacks forming the so-called Golgi ribbon
are broken and the resulting individual stacks become dispersed throughout the
cytoplasm. In the second, Golgi
cisternae further fragment and give rise to the mitotic Golgi haze, which some
claim arises as a result of Golgi proteins being absorbed into the ER (Altan-Bonnet et al. 2006; Reinke et al. 2004), while
others consider it a highly fragmented, ER-independent form of Golgi (Pecot & Malhotra 2004; Axelsson & Warren 2004).
Of these two fragmentation phases, only the first one has been shown to be
essential for mitotic progression and Golgi inheritance, which has in turn led
to the concept of the Golgi checkpoint (Sütterlin et
al. 2002). According to this novel concept, cells check the status of
their Golgis during the late G2 phase of the cell cycle and only enter cell
division once they have ascertained that the Golgi ribbon has fragmented and
the stacks have moved away from the pericentriolar region. Thus, only cells
that are prepared to equitably partition their Golgi into daughter cells enter
into mitosis.
In order to identify components involved in mitotic Golgi fragmentation (MGF), we have previously developed an assay that reconstitutes this process in vitro (Acharya et al. 1998). This assay, which involves incubating purified Golgi membranes with mitotic cytosol and an ATP-regenerating system, has already been used to identify several kinases (Raf1, MEK1 and Plk1) that are needed for MGF to occur (Acharya et al. 1998; Sütterlin et al. 2001; Colanzi et al. 2003b). Also found with this assay to participate in MGF was GRASP65, a peripherally-attached protein of the cis-Golgi membranes. In this case, though, rather than finding an inhibition of MGF upon depletion of GRASP65, what was found was that addition of exogenous GRASP65 inhibits MGF, thus suggesting that GRASP65, rather than being required for MGF, is actually preventing it from happening. Indeed, a recent report has shown that GRASP65 is required for the stability of the Golgi ribbon (Puthenveedu et al. 2006). This, together with the fact that GRASP65 is a known phosphorylation target during mitosis (Preisinger et al. 2005), suggests a model whereby mitotic phosphorylation of GRASP65 is needed in order to break the Golgi ribbon and thus enter mitosis. Currently, our lab is trying to expand this model through the identification of new components involved in MGF and a finer characterization of all the relationships between all the participants in this process.
References:
- Acharya et al. (1998) Cell 92,
183
- Altan-Bonnet et al. (2006) Mol. Biol.
Cell 17, 990
- Axelsson
& Warren (2004) Mol. Biol. Cell 15, 1843
- Bard et al. (2006) Nature 439,
604
- Baron
& Malhotra (2002) Science 295, 325
- Colanzi et al. (2003a) Curr. Opin. Cell
Biol. 15, 462
- Colanzi et al.
(2003b) J. Cell Biol. 161, 27
- Diaz-Añel & Malhotra (2005) J.
Cell Biol. 169, 83
- Hausser
et al. (2005) Nat. Cell Biol. 7,880
- He et al. (2004) J. Cell Biol. 165, 313
- He et al. (2005) Science 310, 1196
- Jamora et al. (1997) Cell 91,
617
- Jamora et al. (1999) Cell
98, 59
- Liljedahl
et al. (2001) Cell 104, 409
- Pecot
& Malhotra (2004) Cell 116, 99
- Pelletier
et al. (2002) Nature 418, 548
- Preisinger et al. (2005) EMBO J. 24,
753
- Puthenveedu et al. (2006) Nat.
Cell. Biol. 8, 238
- Reinke et al. (2004) Proc. Natl. Acad.
Sci. USA 101, 18018
- Rossanese & Glick (2001) Traffic 2, 589
- Shorter & Warren (2002) Annu. Rev. Cell Dev. Biol. 18, 379
- Sütterlin et al. (2001) Proc. Natl. Acad. Sci. USA 98, 9128
- Sütterlin
et al. (2002) Cell 109, 359